Changes in the levels of interferon-γ and transforming growth factor-β influence bronchial stenosis during the treatment of endobronchial tuberculosis

Respiration

Volumn 74, Issue 2, 2007, Pages 202-207

  Kim, Y ^a   Kim, K ^a   Joe, J ^a   Park, H ^a   Lee, M ^a   Choi, Y ^b   Park, S ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University Hospital   (South Korea)

Author keywords

Bronchial stenosis; Endobronchial tuberculosis; Interferon ; Transforming growth factor

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; BRONCHUS STENOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DOSE REDUCTION; ENDOBRONCHIAL TUBERCULOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; RESPIRATORY FUNCTION; TRACHEOBRONCHIAL TOILET; TUBERCULOSIS;

ADULT; AGED; AIRWAY OBSTRUCTION; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; BRONCHIAL DISEASES; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS;

EID: 33847351657     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097491     Document Type: Article

References (22)

1. Raviglione MC, Snider DE Jr, Kochi A: Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995;273:220-226.
2. Ip MS, So SY, Lam WK, Mok CK: Endobronchial tuberculosis revisted. Chest 1986;89:727-730.
3. Smith LS, Schillaci RF, Sarlin RF: Endobronchial tuberculosis: serial fiberoptic bronchoscopy and natural history. Chest 1987;91:644-647.
4. Williams DJ, York EL, Nobert EJ, Sproule BJ: Endobronchial tuberculosis presenting as asthma. Chest 1988;93:836-838.
5. Young LS: Mycobacterial diseases and the compromised host. Clin Infect Dis 1993;17(suppl 2):S436-S441.
6. Turett GS, Telzak EE, Torian LV, Blum S, Alland D, Weisfuse I, Fazal BA: Improved outcomes for patients with multidrug-resistant tuberculosis. Clin Infect Dis 1995;21:1238-1244.
7. Tsao TC, Huang CC, Chiou WK, Yang PY, Hsieh MJ, Tsao KC: Levels of interferon-γ and interleukin-2 receptor-α for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis. Int J Tuberc Lung Dis 2002;6:720-727.
8. Maggi E, Parronchi P, Manetti R, Simonelli C, Piccini MP, Rugiu FS, De Carli M, Ricci M, Romagnani S: Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones . J Immunol 1992;148:2142-2147.
9. Olobo JO, Geletu M, Demissie A, Eguale T, Hiwot K, Aderaye G, Britton S: Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts. Scand J Immunol 2001;53:85-91.
10. Belardelli F: Role of interferons and other cytokines in the regulation of the immune response. APMIS 1995;103:161-179.
11. Chung HS, Lee JH: Bronchoscopic assessment of the evolution of endobronchial tuberculosis. Chest 2000;117:385-392.
12. Shitrit D, Valdsislav P, Grubstein A, Bendayan D, Cohen M, Kramer MR: Accuracy of virtual bronchoscopy for grading tracheobronchial stenosis: correlation with pulmonary function test and fiberoptic bronchoscopy. Chest 2005;128:3545-3550.
13. Hoheisel G, Chan BKM, Chan CHS, Chan KS, Teschler H, Costabel U: Endobronchial tuberculosis: diagnostic features and therapeutic outcome. Respir Med 1994;88:593-597.
14. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG: Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986;60:532-538.
15. Shijubo N, Imai K, Nakanishi F, Yachi A, Abe S: Elevated concentrations of circulating ICAM-1 in far advanced and miliary tuberculosis. Am Rev Respir Dis 1993;148:1289-1301.
16. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR: An essential role of Interferon γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-2254.
17. Dlugovitzky D, Bay ML, Rateni L, Urizar L, Rondelli CFM, Largacha C, Farroni MA, Molteni O, Bottasso OA: In vitro synthesis of interferon-γ , interleukin-4, transforming growth factor-β and interleukin 1-β by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement. Scand J Immunol 1999;49:210-217.
18. Aung H, Toossi Z, McKenna SM, Gogate P, Sierra J, Sada E, Rich EA: Expression of transforming growth factor-β but not tumor necrosis factor-α , interferon-γ , and interleukin-4 in granulomatous lung lesions in tuberculosis. Tuber Lung Dis 2000;80:61-67.
19. Ruscetti F, Varesio L, Ochoa A, Ortaldo J: Pleiotropic effects of transforming growth factor-beta on cells of the immune system. Ann NY Acad Sci 1993;685:488-500.
20. Toossi Z, Ellner JJ: The role of TGF beta in the pathogenesis of human tuberculosis. Clin Immunol Immunopathol 1998;87:107-114.
21. Lee JH, Chung HS: Bronchoscopic, radiologic and pulmonary function evaluation of endobronchial tuberculosis. Respirology 2000;5:411-417.
22. Rooney CP, Ferguson JS, Barnhart W, Cook-Granroth J, Ross A, Hoffman EA, McLennan G: Use of 3-dimensional computed tomography reconstruction studies in the preoperative assessment of patients undergoing balloon dilatation for tracheobronchial stenosis. Respiration 2005;72:579-586.